TR201900492T4 - Montanide ile bir triepitop peptidinin emülsifiye edilmesine yönelik yöntem ve bunun gerçekleştirilmesine yönelik kitler. - Google Patents

Montanide ile bir triepitop peptidinin emülsifiye edilmesine yönelik yöntem ve bunun gerçekleştirilmesine yönelik kitler. Download PDF

Info

Publication number
TR201900492T4
TR201900492T4 TR2019/00492T TR201900492T TR201900492T4 TR 201900492 T4 TR201900492 T4 TR 201900492T4 TR 2019/00492 T TR2019/00492 T TR 2019/00492T TR 201900492 T TR201900492 T TR 201900492T TR 201900492 T4 TR201900492 T4 TR 201900492T4
Authority
TR
Turkey
Prior art keywords
montanide
triepitope
kits
emulsifying
peptide
Prior art date
Application number
TR2019/00492T
Other languages
English (en)
Inventor
Menez-Jamet Jeanne
Original Assignee
Vaxon Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxon Biotech filed Critical Vaxon Biotech
Publication of TR201900492T4 publication Critical patent/TR201900492T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001154—Enzymes
    • A61K39/001157—Telomerase or TERT [telomerase reverse transcriptase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001186—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Mevcut buluş, bir insan özneye uygulamaya yönelik anti-kanser immünoterapide kullanılmaya yönelik, üç epitop ve adjuvan olarak Montanide içeren optimize edilmiş bir polipeptit ile bir aşı formülasyonunun hazırlanmasına yönelik bir yöntem ile ilgilidir.
TR2019/00492T 2013-12-18 2014-12-18 Montanide ile bir triepitop peptidinin emülsifiye edilmesine yönelik yöntem ve bunun gerçekleştirilmesine yönelik kitler. TR201900492T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13306769.4A EP2886127A1 (en) 2013-12-18 2013-12-18 Method for emulsifying a triepitope peptide with montanide and kits for performing the same

Publications (1)

Publication Number Publication Date
TR201900492T4 true TR201900492T4 (tr) 2019-02-21

Family

ID=49885111

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00492T TR201900492T4 (tr) 2013-12-18 2014-12-18 Montanide ile bir triepitop peptidinin emülsifiye edilmesine yönelik yöntem ve bunun gerçekleştirilmesine yönelik kitler.

Country Status (11)

Country Link
US (2) US20170000866A1 (tr)
EP (2) EP2886127A1 (tr)
JP (1) JP6630274B2 (tr)
CN (1) CN106061499B (tr)
CA (1) CA2933260A1 (tr)
DK (1) DK3082854T3 (tr)
ES (1) ES2705706T3 (tr)
PL (1) PL3082854T3 (tr)
PT (1) PT3082854T (tr)
TR (1) TR201900492T4 (tr)
WO (1) WO2015092746A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ741201A (en) * 2015-11-18 2019-09-27 Graphic Packaging Int Llc Carton with handle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2330658T3 (es) * 2005-12-23 2009-12-14 Vaxon Biotech Polipeptido inmunogeno compuesto por peptidos cripticos optimizados derivados de antigenos tumorales, y sus usos.
AU2009287565B2 (en) 2008-09-05 2014-08-07 Oncotherapy Science, Inc. Device and method for automatically preparing emulsion drug
PL2413956T3 (pl) * 2009-04-02 2017-06-30 Vaxon Biotech Identyfikacja, optymalizacja oraz zastosowanie kryptycznych epitopów antygenu hla-a24 na potrzeby immunoterapii

Also Published As

Publication number Publication date
EP3082854B1 (en) 2018-10-17
EP3082854A1 (en) 2016-10-26
ES2705706T3 (es) 2019-03-26
US20190151427A1 (en) 2019-05-23
EP2886127A1 (en) 2015-06-24
DK3082854T3 (en) 2019-02-04
CA2933260A1 (en) 2015-06-25
JP6630274B2 (ja) 2020-01-15
CN106061499A (zh) 2016-10-26
US20170000866A1 (en) 2017-01-05
CN106061499B (zh) 2020-07-17
WO2015092746A1 (en) 2015-06-25
PL3082854T3 (pl) 2019-06-28
PT3082854T (pt) 2019-01-24
JP2017502026A (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
CR20170419A (es) Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el cáncer de páncreas y otros tipos de cáncer.
CR20180027A (es) Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la misma terapia contra el cáncer epitelial de ovario y otros tipos de cáncer.
CR20180174A (es) Nuevos péptidos, combinaciones de péptidos y soportes para el uso en el tratamiento inmunoterapéutico de varios tipos de cáncer
BR112013008700B8 (pt) Molécula de rna auto-replicante, partícula de replicon de alfavírus, composição, molécula de dna recombinante, uso da molécula de rna auto-replicante
CR20160018A (es) Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc)
EA201691631A1 (ru) Иммунотерапия рака с применением комбинации местной и системной иммунной стимуляции
TR201910601T4 (tr) Uçak koltuğu tutma tertibatı.
AR076106A1 (es) Anticuerpos anti-cd40 y usos de los mismos
MX2015015511A (es) Prediccion de la inmunogenicidad en epitopos de celulas t.
CO7111302A2 (es) Antígenos asociados a próstata y regímenes de inmunoterapia basados en vacuna
MX2015008847A (es) Composiciones inmunogenicas de virus de influenza y usos de las mismas.
EA201790239A1 (ru) Молекула-носитель для антигенов
EP3053592A4 (en) T cell-inducing vaccine containing interepitope sequence promoting antigen presentation
ES2681973T3 (es) Respuesta antitumoral contra autoepítopos modificados
EA201590829A1 (ru) Новые мукозные адъюванты и системы доставки
NZ729519A (en) Methods and compositions for intra-nasal immunization with recombinant mva encoding flagellin
EP2998322A4 (en) EPITOPE BASED VACCINE FOR LOW IMMUNOGENICITY PROTEIN AND METHOD FOR PREPARING AND USING SAME
MX2014006630A (es) Vacuna a base toxina clostridium difficile.
MX361230B (es) Polipéptido(s) transportado(s) por cyaa y uso para inducir respuestas inmunes tanto terapéuticas como profilácticas.
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
UY35835A (es) Anticuerpos específicos para FcRn.
MX2015017959A (es) Composiciones y metodos para inmunoterapia.
MX2014011712A (es) Composiciones antigenas y procedimientos.
MX2015013832A (es) Composicion de vacuna y metodo de uso.
AR094904A1 (es) Análogos de insulina y su uso